Long Term follow up with Xofigo
Research payments
$200,452
Through program year 2023, $200,452 in research payments was reported against Long Term follow up with Xofigo, across 122 payments, paid by Bayer HealthCare Pharmaceuticals Inc..
- Paid by
- Bayer HealthCare Pharmaceuticals Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | Research | $21,198 | 15 |
| 2022 | Research | $44,795 | 33 |
| 2021 | Research | $31,536 | 23 |
| 2020 | Research | $38,286 | 24 |
| 2019 | Research | $64,638 | 27 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Ulka Vaishampayan Ann Arbor, MI Named on 18 payments
- Luke Nordquist Omaha, NE Named on 14 payments
- Costantine Albany Indianapolis, IN Named on 13 payments
- Alton Sartor New Orleans, LA Named on 11 payments
- Leonard Appleman Boston, MA Named on 8 payments
- Kalpesh Patel Tucson, AZ Named on 8 payments
- Nabil Adra Indianapolis, IN Named on 6 payments
- Anshu Jain Ashland, KY Named on 6 payments
- Arif Hussain Baltimore, MD Named on 6 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.